Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial

References

• Sengupta N, Breuer J. A global perspective of the epidemiology and burden of varicella-zoster virus. Curr Pediatr Rev 2009; 5:207-28; https://doi.org/10.2174/157339609791317315
   Google Scholar
• Gershon AA, Takahashi M, Seward J. Live attenuated varicella vaccine. In: Plotkin S, Orenstein W, editors. Vaccines. 5th ed. Fourth Edition Elsevers Inc. U.S.A; 2004.
   Google Scholar
• Gould D. Varicella zoster virus: chickenpox and shingles. Nurs Stand 2014; 28:52-8; PMID:24734838; https://doi.org/10.7748/ns2014.04.28.33.52.e8249
   PubMedGoogle Scholar
• Boelle PY, Hanslik T. Varicella in non-immune persons: incidence, hospitalization and mortality rates. Epidemiol Infect 2002; 129:599-606; PMID:12558344; https://doi.org/10.1017/S0950268802007720
   PubMed Web of Science ®Google Scholar
• Jean-Jasmin LM, Lynette SP, Stefan M, Kai CS, Chew FT, Wah LB. Economic burden of varicella in Singapore–a cost benefit estimate of implementation of a routine varicella vaccination. Southeast Asian J Trop Med Public Health 2004; 35:693-6; PMID:15689089
   PubMedGoogle Scholar
• Lokeshwar MR, Agrawal A, Subbarao SD, Chakraborty MS, Ram Prasad AV, Weil J, Bock HL, Kanwal S, Shah RC, Shah N. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr 2000; 37:714-9; PMID:10906803
   PubMedGoogle Scholar
• Baxter R, Tran TN, Ray P, Lewis E, Fireman B, Black S, Shinefield HR, Coplan PM, Saddier P. Impact of vaccination on the epidemiology of varicella: 1995–2009. Pediatrics 2014; 134:24-30; PMID:24913796; https://doi.org/10.1542/peds.2013-4251
   PubMed Web of Science ®Google Scholar
• Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF. Changing varicella epidemiology in active surveillance sites—United States, 1995–2005. J Infect Dis 2008; 197 Suppl 2:S71-5; PMID:18419413; https://doi.org/10.1086/522156
   PubMed Web of Science ®Google Scholar
• Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine 2010; 28:2532-8; PMID:20117265; https://doi.org/10.1016/j.vaccine.2010.01.036
   PubMed Web of Science ®Google Scholar
• Tan B, Bettinger J, McConnell A, Scheifele D, Halperin S, Vaudry W, Law B. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000–2008. Pediatr Infect Dis J 2012; 31:956-63; PMID:22647896; https://doi.org/10.1097/INF.0b013e318260cc4d
   PubMed Web of Science ®Google Scholar
• Pozza F, Piovesan C, Russo F, Bella A, Pezzotti P, Emberti Gialloreti L. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy. Vaccine 2011; 29:9480-7; PMID:22015389; https://doi.org/10.1016/j.vaccine.2011.10.022
   PubMed Web of Science ®Google Scholar
• Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, Sharrar RG. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008; 197 Suppl 2:S165-9; PMID:18419392; https://doi.org/10.1086/522125
   PubMed Web of Science ®Google Scholar
• Lee BW. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 1998; 3:886-90; PMID:9855401; https://doi.org/10.1046/j.1365-3156.1998.00316.x
   PubMed Web of Science ®Google Scholar
• Marin M, Watson TL, Chaves SS, Civen R, Watson BM, Zhang JX, Perella D, Mascola L, Seward JF. Varicella among adults: data from an active surveillance project, 1995–2005. J Infect Dis 2008; 197 Suppl 2:S94-S100; PMID:18419417; https://doi.org/10.1086/522155
   PubMed Web of Science ®Google Scholar
• Diaz-Mitoma F, Halperin SA, Scheifele D. Reactogenicity to a live attenuated varicella vaccine in Canadian children. Can J Infect Dis 2000; 11:97-101; PMID:18159273; https://doi.org/10.1155/2000/647245
   PubMedGoogle Scholar
• Doerr HW. Progress in VZV vaccination? Some concerns. Med Microbiol Immunol 2013; 202:257-8; PMID:23649706; https://doi.org/10.1007/s00430-013-0298-x
   PubMed Web of Science ®Google Scholar
• White CJ, Kuter BJ, Hildebrand CS, Isganitis KL, Matthews H, Miller WJ, Provost PJ, Ellis RW, Gerety RJ, Calandra GB. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989. Pediatrics 1991; 87:604-10.
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global Varicella Vaccine Effectiveness: A Meta-analysis. Pediatrics 2016; 137:e20153741; PMID:26908671; https://doi.org/10.1542/peds.2015-3741
   PubMed Web of Science ®Google Scholar
• Seward JF, Marin M, Vazquez M. Varicella vaccine effectiveness in the US vaccination program: a review. J Infect Dis 2008; 197 Suppl 2:S82-9; PMID:18419415; https://doi.org/10.1086/522145
   PubMed Web of Science ®Google Scholar
• Kuter BJ, Ngai A, Patterson CM, Staehle BO, Cho I, Matthews H, Provost PJ, White CJ. Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group. Vaccine 1995; 13:967-72.
   PubMed Web of Science ®Google Scholar
• Mitra M, Faridi M, Ghosh A, Shah N, Shah R, Chaterjee S, Narang M, Bhattacharya N, Bhat G, Choudhury H et al. Safety and immunogenicity of single dose live attenuated varicella vaccine (VR 795 Oka strain) in healthy Indian children: a randomized controlled study. Hum Vaccin Immunother 2015; 11:443-9; PMID:25692656; https://doi.org/10.4161/21645515.2014.979646 10.1080/21645515.2014.1004031
   PubMed Web of Science ®Google Scholar
• Maple PA, Gray J, Breuer J, Kafatos G, Parker S, Brown D. Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay. Clin Vaccine Immunol 2006; 13:214-8; PMID:16467328; https://doi.org/10.1128/CVI.13.2.214-218.2006
   PubMed Web of Science ®Google Scholar
• Li S, Chan IS, Matthews H, Heyse JF, Chan CY, Kuter BJ, Kaplan KM, Vessey SJ, Sadoff JC. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J 2002; 21:337-42; PMID:12075766; https://doi.org/10.1097/00006454-200204000-00014
   PubMed Web of Science ®Google Scholar
• Saurbrei A, Wutzler P. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen. J Clin Microbiol 2006; 44:3094-7; PMID:16954232; https://doi.org/10.1128/JCM.00719-06
   PubMed Web of Science ®Google Scholar
• Bartoloni A, Bartalesi F, Roselli M, Mantella A, Dini F, Carballo ES, Barron VP, Paradisi F. Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia. Trop Med Int Health 2002; 7:512-7; PMID:12031073; https://doi.org/10.1046/j.1365-3156.2002.00852.x
   PubMed Web of Science ®Google Scholar
• Allami A, Mohammadi N. Varicella immunity in Iran: an age-stratified systematic review and meta-analysis. Iran J Microbiol 2014; 6:372-81; PMID:25926953
   PubMedGoogle Scholar
• Kudesia G, Partridge S, Farrington CP, Soltanpoor N. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J Clin Pathol 2002; 55:154-5; PMID:11865016; https://doi.org/10.1136/jcp.55.2.154
   PubMed Web of Science ®Google Scholar
• Garg P, Garg SP, Sharma MK, Sahani S. Phase-I, open, unicentric clinical trial for evaluation of safety of varicella vaccine, live (I.P.) (Oka strain) in adults. Biotechnology International 2014; 7:26-34.
   Google Scholar
• Provost PJ, Krah DL, Kuter BJ, Morton DH, Schofield TL, Wasmuth EH, White CJ, Miller WJ, Ellis RW. Antibody assays suitable for assessing immune responses to live varicella vaccine. Vaccine 1991; 9:111-6; PMID:1647574
   PubMed Web of Science ®Google Scholar
• Maple PA, Breuer J, Quinlivan M, Kafatos G, Brown KE. Comparison of a commercial Varicella Zoster glycoprotein IgG enzyme immunoassay with a reference time resolved fluorescence immunoassay (VZV TRFIA) for measuring VZV IgG in sera from pregnant women, sera sent for confirmatory testing and pre and post vOka vaccination sera from healthcare workers. J Clin Virol 2012; 53:201-7; PMID:22261123
   PubMed Web of Science ®Google Scholar